ArticleChinese journal of cancer2013

A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin.

Zhi-Gang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.